Elicio Therapeutics, Inc. (ELTX)
1.68
-0.07
(-4.00%)
USD |
NASDAQ |
Oct 30, 16:00
1.695
+0.02
(+0.89%)
After-Hours: 20:00
Elicio Therapeutics Market Cap : 36.79M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 36.79M |
| October 29, 2026 | 38.33M |
| October 28, 2026 | 40.52M |
| October 27, 2026 | 40.08M |
| October 26, 2026 | 37.23M |
| October 23, 2026 | 41.61M |
| October 22, 2026 | 42.49M |
| October 21, 2026 | 36.58M |
| October 20, 2026 | 34.39M |
| October 19, 2026 | 33.95M |
| October 16, 2026 | 34.17M |
| October 15, 2026 | 38.98M |
| October 14, 2026 | 39.20M |
| October 13, 2026 | 38.77M |
| October 12, 2026 | 41.18M |
| October 09, 2026 | 41.39M |
| October 08, 2026 | 39.64M |
| October 07, 2026 | 40.52M |
| October 06, 2026 | 41.18M |
| October 05, 2026 | 42.05M |
| October 02, 2026 | 42.05M |
| October 01, 2026 | 42.05M |
| September 30, 2026 | 39.86M |
| September 29, 2026 | 40.30M |
| September 28, 2026 | 40.52M |
| Date | Value |
|---|---|
| September 25, 2026 | 40.30M |
| September 24, 2026 | 41.18M |
| September 23, 2026 | 40.96M |
| September 22, 2026 | 40.96M |
| September 21, 2026 | 41.83M |
| September 18, 2026 | 41.39M |
| September 17, 2026 | 40.85M |
| September 16, 2026 | 38.77M |
| September 15, 2026 | 43.58M |
| September 14, 2026 | 43.80M |
| September 11, 2026 | 44.90M |
| September 10, 2026 | 46.21M |
| September 09, 2026 | 47.75M |
| September 08, 2026 | 51.47M |
| September 04, 2026 | 52.78M |
| September 03, 2026 | 54.75M |
| September 02, 2026 | 55.85M |
| September 01, 2026 | 56.07M |
| August 31, 2026 | 59.13M |
| August 28, 2026 | 62.20M |
| August 27, 2026 | 65.70M |
| August 26, 2026 | 65.27M |
| August 25, 2026 | 65.92M |
| August 24, 2026 | 65.27M |
| August 21, 2026 | 66.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lineage Cell Therapeutics, Inc. | 252.91M |
| Armata Pharmaceuticals, Inc. | 121.84M |
| Voyager Therapeutics, Inc. | 105.39M |
| Black Diamond Therapeutics, Inc. | 102.25M |
| Invivyd, Inc. | 171.46M |
Market Cap Related Metrics
| Price to Book Value | 4.636 |
| Price | 1.68 |
| Earnings Yield | -125.8% |